NCT06177392

Brief Summary

SUMMARY: The investigators are planning a clinical study to compare two methods of performing a procedure called TAVI, used in patients with severe aortic stenosis. In this procedure, the aortic valve is replaced in a less invasive way. Traditionally, access through the groin (femoral) is used, but now radial access (through the wrist) is being considered as an alternative. Reasons for the Study:

  • Currently, there is not enough solid evidence to support the choice between these two accesses.
  • The investigators want to understand if radial access could be safer and have fewer complications compared to femoral access. What the Investigators Will Measure:
  • Major complications, such as bleeding or vascular injuries.
  • Other important outcomes, such as functional recovery and quality of life. How the Investigators Will Do It:
  • The investigators will randomize patients to receive radial or femoral access.
  • The investigators will record which type of access is used and assess complications and outcomes.
  • The investigators will compare the results to understand if there are significant differences between the two groups. Ultimate Goal:
  • The investigators aim to improve the safety and efficacy of this procedure for patients.
  • The results of this study will help doctors make informed decisions on how to perform TAVI. Conclusion: \- This study is crucial for enhancing care for patients with aortic stenosis and ensuring the procedure is performed in the safest and most effective manner. The results will benefit patients and guide doctors in choosing the best approach for each individual.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2024

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 11, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 20, 2023

Completed
19 days until next milestone

Study Start

First participant enrolled

January 8, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

January 5, 2024

Status Verified

January 1, 2024

Enrollment Period

1.7 years

First QC Date

December 11, 2023

Last Update Submit

January 3, 2024

Conditions

Keywords

RADIAL ACCESSRADIAL SECONDARY ACCESSTAVISEVERE AORTIC STENOSISVASCULAR COMPLICATIONSVARC-3

Outcome Measures

Primary Outcomes (1)

  • ACCESS RELATED OR BLEEDING COMPLICATIONS

    Major and minor access-related complications (VARC-3) and major or greater (VARC ≥2) bleeding complications (BARC)

    From the enrollment to 4 weeks after the procedure.

Secondary Outcomes (4)

  • MACE

    From the enrollment to 4 weeks after the procedure.

  • bleeding

    From the enrollment to 4 weeks after the procedure.

  • Quality of life scale

    4 weeks after the procedure

  • Complications not directly TAVI procedure-related

    From the enrollment to 4 weeks after the procedure.

Study Arms (2)

RADIAL

EXPERIMENTAL

RADIAL ARTERY ACCESS AS SECONDARY ACCESS IN TAVI PROCEDURE

Procedure: Secondary TAVI access

FEMORAL

ACTIVE COMPARATOR

FEMORAL ARTERY ACCESS AS SECONDARY ACCESS IN TAVI PROCEDURE

Procedure: Secondary TAVI access

Interventions

The randomization will determine whether radial or femoral artery puncture will be employed as the secondary access in the TAVI procedure.

FEMORALRADIAL

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients with severe aortic stenosis and candidates for transfemoral TAVI.
  • Secondary access possible through both radial and femoral routes.
  • Capacity to provide informed consent.

You may not qualify if:

  • Specific contraindications for radial or femoral access.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Aortic Valve Stenosis

Condition Hierarchy (Ancestors)

Aortic Valve DiseaseHeart Valve DiseasesHeart DiseasesCardiovascular DiseasesVentricular Outflow Obstruction

Central Study Contacts

Daniel Tébar Márquez DTM Daniel Tébar Márquez, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor of medicine

Study Record Dates

First Submitted

December 11, 2023

First Posted

December 20, 2023

Study Start

January 8, 2024

Primary Completion

October 1, 2025

Study Completion

December 1, 2025

Last Updated

January 5, 2024

Record last verified: 2024-01